Recombinant Human NAP-2 (CXCL7) 0 ComentariosSubmit a Review Detalles del Producto Nùmero de Catalogo 300-14 Descripcion NAP-2 is a CXC chemokine that can signal through the CXCR1 and CXCR2 receptors. It is produced in leukocytes by enzymatic processing of a precursor called platelet basic protein (PBP). NAP-2 chemoattracts and activates neutrophils. Recombinant Human NAP-2 protein is a 7.6 kDa protein containing 70 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines, and also the “ELR” motif, common to CXC chemokines that bind to CXCR1 and CXCR2. Source: E.coli Synonyms: Neutrophil Activating Protein-2, CXCL7, PBP (parent molecule), CTAP-III (precursor) AA Sequence: AELRCMCIKT TSGIHPKNIQ SLEVIGKGTH CNQVEVIATL KDGRKICLDP DAPRIKKIVQ KKLAGDESAD Purity: ≥ 98% by SDS-PAGE gel and HPLC analyses. Biological Activity: Determined by its ability to chemoattract human neutrophils using a concentration range of 1.0-10.0 ng/ml. Calculated Molecular Weight: 7.6 kDa Accession Number: P02775 Gene ID: 5473 Endotoxin: Endotoxin level is < 0.1 ng/ug of protein (< 1 EU/ug) crossreactivity: Bacteria, Hamster, Human, Mouse References PubMed SDS Búsqueda del CoA Product Line Country Of Origin: USA Not for human use. Research Interest Chemotaxis Immune System Wound Healing product.subtitle.recentcitations Primer autor Du, Y Titulo Chemokines form nanoparticles with DNA and can superinduce TLR-driven immune inflammation. Citar The Journal of Experimental Medicine; 219(7) PudMed id 35640018 Primer autor Lee, A W Titulo A knottin scaffold directs the CXC-chemokine-binding specificity of tick evasins. Citar The Journal of Biological Chemistry; 294(29) pg11199-11212 PudMed id 31167786 Primer autor Alenazi, Y Titulo Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsets. Citar Scientific Reports; 8(1) pg6333 PudMed id 29679010
